Product Profile of Gefitinib Tablet For Cancer
Gefitinib Tablet for Cancer is composed of lactose monohydrate, microcrystalline cellulose, croscarmellose sodium, povidone, sodium lauryl sulphate and magnesium stearate. The Tablet comes coated with hydroxypropyl methylcellulose, polyethylene glycol 300, titanium dioxide, red ferric oxide and yellow ferric oxide. The Gefitinib Tablet for Cancer has strength of 250 mg per dosage.
Key Features of Gefitinib Tablet For Cancer
- Composed of lactose monohydrate, microcrystalline cellulose, croscarmellose sodium, povidone, sodium lauryl sulphate and magnesium stearate.
- Coated with hydroxypropyl methylcellulose, polyethylene glycol 300, titanium dioxide, red ferric oxide and yellow ferric oxide
- Strength of 250 mg per dosage.
- Used for certain breast, lung and other cancers.
- EGFR inhibitor.
- Packing: 3 X 10.
- Not suitable for pregnant women.